Magdadaro, Jinael C.
HRN: 20-52-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2026
CEFTRIAXONE 1G (VIAL)
07/16/2026
07/23/2026
IV
1g
Q12
For Removal Of Implant
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes